Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.980
-0.010 (-0.25%)
At close: Jan 16, 2026, 4:00 PM EST
4.029
+0.049 (1.23%)
After-hours: Jan 16, 2026, 7:59 PM EST
Prime Medicine Employees
Prime Medicine had 214 employees as of December 31, 2024. The number of employees decreased by 20 or -8.55% compared to the previous year.
Employees
214
Change (1Y)
-20
Growth (1Y)
-8.55%
Revenue / Employee
$27,930
Profits / Employee
-$922,145
Market Cap
704.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 214 | -20 | -8.55% |
| Dec 31, 2023 | 234 | 59 | 33.71% |
| Dec 31, 2022 | 175 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRME News
- 2 days ago - Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 16 days ago - Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond - Seeking Alpha
- 5 weeks ago - Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease - GlobeNewsWire
- 7 weeks ago - Prime Medicine to Present at 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 2 months ago - Prime Medicine, Inc. (PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease Transcript - Seeking Alpha
- 2 months ago - Prime Medicine to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire